In the context of Alzheimer’s disease, the Akt pathway plays a fundamental role as one of the most potent inhibitors of GSK3, the main kinase that drives tau phosphorylation [151,181]. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.